CD4 and lung carcinoma: In addition, Syllogist performed similarly to all tested methods in estimating CD4 and CD8 T cell subsets in transcriptome data of melanoma and lung cancer tissues paired with quantitative immunofluorescence data22 (Fig. 1d).